These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10695472)

  • 21. Cardiac surgery: postoperative arrhythmias.
    Chung MK
    Crit Care Med; 2000 Oct; 28(10 Suppl):N136-44. PubMed ID: 11055682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
    Sengupta J; Abdelhadi R
    Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure.
    Stevenson WG; Stevenson LW; Weiss J; Tillisch JH
    Am Heart J; 1988 Dec; 116(6 Pt 1):1447-54. PubMed ID: 3195428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arrhythmias in hypertrophic cardiomyopathy.
    Kuck KH
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2706-13. PubMed ID: 9358518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dangerous arrhythmias].
    Gertsch M; Fuhrer J
    Schweiz Med Wochenschr; 1993 May; 123(17):833-43. PubMed ID: 8497770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmias and their treatment in patients with heart failure.
    Rehnqvist N
    Am J Cardiol; 1989 Dec; 64(20):61J-64J. PubMed ID: 2688390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P; Pott C; Eckardt L; Breithardt G
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inflammation of the myocardium as an arrhythmia trigger].
    Klein RM; Vester EG; Brehm MU; Dees H; Picard F; Niederacher D; Beckmann MW; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():24-35. PubMed ID: 10810782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms and management of arrhythmias in heart failure.
    Stevenson WG
    Curr Opin Cardiol; 1995 May; 10(3):274-81. PubMed ID: 7612977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia.
    Yuge M; Niwano S; Moriguchi M; Sasaki T; Hirasawa S; Imaki R; Sato D; Izumi T
    Circ J; 2006 Mar; 70(3):268-72. PubMed ID: 16501291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current approaches to antiarrhythmic therapy in heart failure.
    Rose-Jones LJ; Bode WD; Gehi AK
    Heart Fail Clin; 2014 Oct; 10(4):635-52. PubMed ID: 25217438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on management of cardiac arrhythmias in acute coronary syndromes.
    Willich T; Goette A
    Minerva Cardioangiol; 2015 Apr; 63(2):121-33. PubMed ID: 25612305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK; Zipes DP
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current approaches to evaluation and management of patients with ventricular arrhythmias.
    Buxton AE; Kirk MM; Michaud GF
    Med Health R I; 2001 Feb; 84(2):58-62. PubMed ID: 11272662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of ventricular arrhythmias.
    McGovern BA; Garan H; Ruskin JN
    Curr Probl Cardiol; 1988 Dec; 13(12):785-859. PubMed ID: 3064973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.